MNMD 7.16 (+2.14%)
CA60255C8850BiotechnologyBiotechnology

Mind Medicine (MNMD) Stock Highlights

7.16 | +2.14%
2024-12-21 05:11:23
Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

Statistics

Range Today
6.92 7.36
Volume Today 1.77M
Range 1 Year
3.35 12.22
Volume 1 Year 354.36M
Range 3 Year
2.12 25.65
Volume 3 Year 630.23M
Range 10 Year
0.01 86.55
Volume 10 Year 753.41M

Highlights

Market Capitalization 622.59M (small)
Floating Shares 66.03M
Current Price 7.16
Price To Earnings -3.34
Price To Book 2.64
Earnings Per Share -2.3
Payout Ratio 0%

Performance

Latest +2.14%
1 Month -0.56%
3 Months +13.83%
6 Months -2.19%
1 Year +100.56%
3 Years -71.76%
5 Years +71500%
10 Years +111.83%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.